AGBL Egypt has announced the first full SARS-CoV2 sequencing in Egypt. The successful sequencing of the virus was performed at the National Research Center (NRC) using an NGS sequencing technology solution supplied and supported by AGBL Egypt.
Mr. Amro Negm, Country Sales Manager at AGBL Egypt, said, “We’re proud to be a part of the first full SARS-CoV2 sequence in Egypt. The AGBL Egypt team has been working selflessly to make sure we support our partners in their diagnostic and research efforts to combat the virus.”
Please read the Press Release https://bit.ly/31klXku
About AGBL Egypt
AGBL Egypt is a member of the AGBL group of companies, the largest biomedical distribution group in the Middle East, Africa, and Asia region. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic centers in emerging healthcare markets. AGBL Egypt is headquartered in Cairo and covers Egypt and Sudan.